The use of gadolinium in the MR evaluation of musculoskeletal tumors

Mark J. Kransdorf

Research output: Contribution to journalReview articlepeer-review

9 Scopus citations


Magnetic resonance (MR) imaging has emerged as the preferred modality for the imaging evaluation of musculoskeletal tumors. Although there is general agreement on the value of MR in diagnosis and staging, the use of intravenous contrast in the evaluation of musculoskeletal lesions remains controversial. The purpose of this review is to highlight these controversies, to put them in perspective, arid to suggest recommendations for the use of gadopentetate dimeglumine. The following specific areas will be addressed: (a) evaluation of soft-tissue tumors, (b) diagnosis of low-grade chondrosarcoma and the use of contrast material in identification of intraosseous metastases, (c) monitoring response to chemotherapy, (d) evaluation for local recurrence after surgery and/or radiation therapy, and (e) selection of biopsy site.

Original languageEnglish (US)
Pages (from-to)15-23
Number of pages9
JournalTopics in Magnetic Resonance Imaging
Issue number1
StatePublished - Feb 1996


  • Bone neoplasms
  • Gadolinium
  • Magnetic resonance imaging
  • Musculoskeletal neoplasms
  • Postoperative changes
  • Soft-tissue neoplasms

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging


Dive into the research topics of 'The use of gadolinium in the MR evaluation of musculoskeletal tumors'. Together they form a unique fingerprint.

Cite this